SIMONS; Keith

Patent Applications and Registrations

Patent applications and USPTO patent grants for SIMONS; Keith.The latest application filed is for "epinephrine fine particles and methods for use thereof".

Company Profile

4.6.15

SIMONS; Keith - Winnipeg CA
SIMONS; Keith - Ft. Lauderdale FL US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Epinephrine Fine Particles And Methods For Use Thereof App 20220218629 - RAWAS-QALAJI; Mutasem ; et al.	2022-07-14
Method for increasing plasma concentration of epinephrine in a subject having a condition responsive to epinephrine Grant 11,246,843 - Rawas-Qalaji , et al. February 15, 2	2022-02-15
Compositions including epinephrine microcrystals Grant 11,229,613 - Rawas-Qalaji , et al. January 25, 2	2022-01-25
Epinephrine nanoparticles encapsulated with chitosan and tripolyphosphate, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine Grant 10,568,836 - Rawas-Qalaji , et al. Feb	2020-02-25
Epinephrine Nanoparticles, Methods of Fabrication Thereof, And Methods for Use Thereof for Treatment of Conditions Responsive to App 20190231716 - RAWAS-QALAJI; Mutasem ; et al.	2019-08-01
Epinephrine Microcrystals And Methods For Use Thereof App 20190125698 - RAWAS-QALAJI; Mutasem ; et al.	2019-05-02
Sublingual compositions including epinephrine nanoparticles Grant 10,251,849 - Rawas-Qalaji , et al.	2019-04-09
Methods for use of epinephrine fine particles for treatment of conditions responsive to epinephrine Grant 10,159,656 - Rawas-Qalaji , et al. Dec	2018-12-25
Epinephrine Nanoparticles, Methods Of Fabrication Thereof, And Methods For Use Thereof For Treatment Of Conditions Responsive To Epinephrine App 20180147145 - Rawas-Qalaji; Mutasem ; et al.	2018-05-31
Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine Grant 9,877,921 - Rawas-Qalaji , et al. January 30, 2	2018-01-30
Epinephrine Fine Particles And Methods For Use Thereof For Treatment Of Conditions Responsive To Epinephrine App 20170020827 - RAWAS-QALAJI; Mutasem ; et al.	2017-01-26
Epinephrine Nanoparticles, Methods Of Fabrication Thereof, And Methods For Use Thereof For Treatment Of Conditions Responsive To Epinephrine App 20170000735 - RAWAS-QALAJI; Mutasem ; et al.	2017-01-05
Epinephrine Nanoparticles, Methods Of Fabrication Thereof, And Methods For Use Thereof For Treatment Of Conditions Responsive To Epinephrine App 20160374966 - RAWAS-QALAJI; Mutasem ; et al.	2016-12-29
Epinephrine Fine Particles And Methods For Use Thereof For Treatment Of Conditions Responsive To Epinephrine App 20160045457 - RAWAS-QALAJI; Mutasem ; et al.	2016-02-18
Epinephrine Nanoparticles, Methods Of Fabrication Thereof, And Methods For Use Thereof For Treatment Of Conditions Responsive To Epinephrine App 20150164827 - Rawas-Qalaji; Mutasem ; et al.	2015-06-18
Epinephrine Nanoparticles, Methods Of Fabrication Thereof, And Methods For Use Thereof For Treatment Of Conditions Responsive To Epinephrine App 20140242177 - Rawas-Qalaji; Mutasem ; et al.	2014-08-28
Fast-disintegrating Epinephrine Tablets For Buccal Or Sublingual Administration App 20070202163 - RAWAS-QALAJI; Mutasem ; et al.	2007-08-30
Fast-disintegrating Epinephrine Tablets For Buccal Or Sublingual Administration App 20070059361 - Rawas-Qalaji; Mutasem ; et al.	2007-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.